Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXH3IM
|
||||
Drug Name |
7-(3-(3,3-difluoroazetidin-1-yl)propoxy)-4-(4-methoxyphenyl)-2-methyl-1,2,3,4-tetrahydroisoquinoline
|
||||
Synonyms |
CHEMBL396703
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C23H28F2N2O2
|
||||
Canonical SMILES |
COc1ccc(cc1)C2CN(C)Cc3cc(OCCCN4CC(F)(F)C4)ccc23
|
||||
InChI |
InChI=1S/C23H28F2N2O2/c1-26-13-18-12-20(29-11-3-10-27-15-23(24,25)16-27)8-9-21(18)22(14-26)17-4-6-19(28-2)7-5-17/h4-9,12,22H,3,10-11,13-16H2,1-2H3
|
||||
InChIKey |
AUMQJULFKZREJZ-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Histamine H3 receptor | Target Info | [1587926] | ||
Sodium-dependent serotonin transporter | Target Info | [1587926] | |||
NetPath Pathway | TCR Signaling Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.